Patterns of papillary muscle ischemia in myocardial PET

Adam P Steinmetz1, Michael N Maisey, Ruth Hardoff

  • 1Department of Nuclear Medicine, Rabin Medical Center, Beilinson Campus, Petach-Tikva, Israel. adamst@zahav.net.il

Clinical Nuclear Medicine
|December 23, 2003
PubMed
Abstract

Insights

Positron emission tomography (PET) can visualize papillary muscles (PM), unlike conventional equipment. Myocardial PET imaging reveals various PM pathologies including ischemia and hibernation, offering a new noninvasive study method.

Area of Science:

  • Cardiovascular Imaging
  • Nuclear Medicine
  • Cardiac Physiology

Background:

  • Conventional nuclear medicine lacks the spatial resolution to visualize papillary muscles (PM).
  • Papillary muscles are crucial for cardiac function and can be affected by various pathologies.
  • Positron emission tomography (PET) offers superior spatial resolution for cardiac imaging.

Observation:

  • Myocardial PET imaging successfully visualized papillary muscles in four patients.
  • Distinct patterns of PM abnormalities were observed, correlating with specific pathologic conditions.
  • N-13 ammonia and F-18 FDG were used as perfusion and metabolic agents, respectively.

Findings:

  • PET imaging identified varying degrees of PM ischemia, infarction, and hibernation.
  • Specific PET patterns allowed for the characterization of PM perfusion and metabolic status.
  • Normal PM visualization on F-18 FDG PET images was also demonstrated.

Implications:

  • Myocardial PET is a promising noninvasive tool for assessing papillary muscle health.
  • This technique can potentially diagnose and monitor conditions affecting PM.
  • Enhanced visualization of PM may improve understanding of cardiac disease mechanisms.